Вы находитесь на странице: 1из 4

NobelProcera,

, 2


 ,

 , ,





5-

:  ,
ASTM F136
(25500C):
10,16
: 1640C
:  6% , 4% (Ti6Al4V).
0,05%, 0,08%,
0,012%, 0,25%,
0,13%, 5,506,50%,
3,504,50%. .
:
860
:
795
: 10%


 ,
10,16



,
 ,

NobelProcera VITA,
VITA Titankeramik NobelProcera

 VITA Titankeramik
VITA SYSTEM 3D-MASTER VITA A1D4
 VITA
Al2O3
130 23 .


VITA
www.vita-zahnfabrik.com

NobelProcera,

14
0,4


(.
).

*
* 2010 .

.
=
[]
e= []

.

[] /
[2]

a 21,0

3.0 2.5 / 6.0

Connector
design
requirements
Connector
design
requirements
Bridge
Bridge
Zirconia
NobelProcera
Zirconia
NobelProcera

21,0 < a 35,0


The The
connector
dimension
of a of
multiple
unit unit
framework
depends
on on
connector
dimension
a multiple
framework
depends

e 10,0
the distance
between
and and
the supporting
teeth.
the distance
between
the supporting
teeth.

totaltotal
bridge
design
mustmust
fit into
a disc
of a of
a
60mm
H
20mm.
bridge
design
fit into
a disc
60mm
H 20mm.
tsThe The
- any- any Maximum
length
Minimum
connector
a Type
Type
Maximum
length
Minimum
connector
position
and and
cross
section
position
cross
section

4.0 3.0 / 9.4

Definition
of a and
Definition
of aeand e

4.0 3.0 / 9.4


e

a=Arc a=Arc
length length
[mm] [mm]
2
e=Extension
length length
[mm] [mm] height height
x widthx [mm]
area /[mm
e=Extension
width/[mm]
area] [mm2]

FreeFree
hanging
arc arc
hanging

a 21.0
a 21.0

3.0 x3.0
2.5x /2.5
6.0/ 6.0

e 10.0
e 10.0

4.0 x4.0
3.0x /3.0
9.4/ 9.4

Extension
Extension

mm H 20mm.

rk depends
onarc arc 21.021.0
of a and
FreeFree
hanging
4.0 xe4.0
3.0x /3.0
9.4/ 9.4
< aDefinition
< 35.0
hanging
a 35.0

m connector
oss section

h [mm] / area [mm2]

x 2.5 / 6.0

x 3.0 / 9.4

x 3.0 / 9.4

9
Handling
guidelines
for NobelProcera
zirconia
copings
and frameworks
9
Handling
guidelines
for NobelProcera
zirconia
copings
and frameworks

,


80 80 30 ( )



,
.

delines for NobelProcera zirconia copings and frameworks 9

NobelProcera ,
NobelProcera 5- ;
NobelProcera Product Warranty
NobelProcera -
. ,
NobelProcera.

NobelProcera

NobelProcera

Titanium

Titanium

CERTIFICATE

Nobel Biocare certifies


that the core material
provided to the laboratory
with this certificate is FDA
cleared Titanium.

CERTIFICATE

Material composition; Unalloyed Titanium or Alloyed


Titanium-6Aluminum-4Vanadium (Ti6Al4V).
Nitrogen 0.05%, Carbon 0.08%, Hydrogen
0.015%, Iron 0.30%, Oxygen 0.25%, Titanium =
balance. For Ti6Al4V also; Aluminum 6.50%,
Vanadium 4.50%.

Material composition;
Unalloyed Titanium or Alloyed
Titanium-6Aluminum4Vanadium (Ti6Al4V).
Nitrogen 0.05%, Carbon
0.08%, Hydrogen 0.015%,
Iron 0.30%, Oxygen
0.25%, Titanium = balance.
For Ti6Al4V also; Aluminum
6.50%, Vanadium 4.50%.

Clinician Copy

Dental Laboratory Copy

NobelProcera



,
, , .
, ,
.


NobelProcera Nobel Biocare
, .
Ti-6Al-4V (, 6% , 4% ) ASTM F136,
,
.

, , .
,
.

[4] Williams D.F., Definitions in Biomaterials. Proceedings of a consensus

,
,
, .. .
, , .

. ,
, ,
( ).

. in vitro in vivo
.
,
,
, ()
, .
, Ti-6Al-4V

,

.

[1] ASTM F136-02a standard wrought 6-aluminiumum 4-vanadium


ELI (extra low interstitial) alloy for surgical implant applications
[2] IS0 5832-3, Implants for surgery metallic materials Part 3:
Wrought titanium 6-aluminium 4-vanadium alloy
[3] Steinemann S.G. Titanium-the material of choice? Periodontology
2000. 1998: 17 (1): 721
Conference of the European Society for Biomaterials, England, March 35,
Vol4, Elsevier, NY, 1987
[5] Bardos D.I., Titanium and Titanium Alloys. In: Medical and Dental
Materials, edited by D. Williams, Pergamon Press, 1990: 360365
[6] Schenk R.. The corrosion properties of Titanium and Titanium Alloys. In:
Titanium in Medicine, edited by D. M. Brunette, P. Tengvall, M. Textor, and P.
Thomsen, Berlin & Heidelberg: Springer-Verlag, 2001: 145170
[7] Watanabe I., Wataha J.C., Lockwood P.E., Shimizu H., Cai Z., Okabe T.
Cytotoxicity of commercial and novel binary titanium alloys with and without a
surface-reaction layer, Journal of Oral Rehabilitation, 2004: Volume 31 Issue
2, 185189
[8] Pennekamp P.H., Gessmann J., Diedrich O., Burian B., Wimmer M.A.,
Frauchiger V.M., Kraft C.N. Short-term microvascular response of striated
muscle to cp-Ti, Ti-6Al-4V, and Ti-6Al-7Nb, Journal of Orthopaedic Research,
2006: Volume 24 Issue 3, 531540
[9] Takamura K., Hayashi K., Ishinishi N., Yamada T., Sugioka Y. Evaluation of
carcinogenicity and chronic toxicity associated with orthopaedic implants in
mice. J Biomed Mater. 1994: Res 28 (5): 583589
[10] Mc Cracken M., Dental implant materials: Commercially pure titanium and
titanium alloys, Journal of Prosthodontics, 2005: Volume 8 (1), 4043
[11] Rungcharassaeng K., Lozada J.L., Kan J.Y.K., Kim J.S., Campagni W.V.,
Munoz C.A. Peri-implant tissue response of immediately loaded, threaded,
HA-coated implants: 1 year results
[12] Proussaefs P., Histologic evaluation of an immediately loaded titanium
provisional implant retrieved after functioning for 18 months: A clinical report.
The journal of prosthetic dentistry, 2003: volume 89 (4), 331334
[13] Proussaefs P., Olivier H., Lozada J., Histologic evaluation of a 12 yearold threaded HAcoated implant in conjunction with subantral augmentation
procedure: A clinical report. The journal of prosthetic dentistry,
2004: volume 92 (1), 1721
[14] Thomas P., Thomsen M.. Allergiediagnostik bei Metallimplantatunvertrgli
chkeit, Der Orthopde, 2, 2008

www.nobelbiocare.com

GEN 83929 RU 1004 Nobel Biocare Services AG, 2010 . .


Nobel Biocare, Nobel Biocare Nobel Biocare, . .
VITA Titankeramik VITA Zahnfabrik H. Rauter GmbH & Co.KG.